Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

OpGen to Acquire AdvanDx; Closes $6M Financing from Merck GHI

OpGen said today it agreed to acquire molecular diagnostics developer AdvanDx for an undisclosed price. The deal adds ...

Forward this item to a colleague:

(Separate multiple addresses by commas)